Bosh sahifaSUNPHARMA • NSE
Sun Pharmaceutical Industries Ltd
1 688,00 ₹
11-iyn, 13:16:01 (GMT+5:30) · INR · NSE · Ogohlantirish
AksiyalarIN qimmatli qogʻoziBosh shtabi: IN
Yopilish kursi
1 688,80 ₹
Kunlik diapazon
1 679,30 ₹ - 1 694,80 ₹
Yillik diapazon
1 460,90 ₹ - 1 960,35 ₹
Bozor kapitalizatsiyasi
4,05 trln INR
Oʻrtacha hajm
2,82 mln
Narx/foyda
35,78
Dividend daromadliligi
0,95%
Asosiy maydon
NSE
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(INR)mar, 2025Y/Y qiyosi
Daromad
129,59 mlrd8,14%
Joriy xarajat
75,61 mlrd20,16%
Sof foyda
21,50 mlrd-19,01%
Sof foyda marjasi
16,59-25,10%
Har bir ulushga tushum
10,01-13,02%
EBITDA
34,05 mlrd9,13%
Amaldagi soliq stavkasi
33,68%
Jami aktivlari
Jami passivlari
(INR)mar, 2025Y/Y qiyosi
Naqd pul va qisqa investitsiyalar
249,88 mlrd30,89%
Jami aktivlari
921,01 mlrd7,77%
Jami passivlari
196,15 mlrd6,85%
Umumiy kapital
724,86 mlrd
Tarqatilgan aksiyalar
2,39 mlrd
Narxi/balansdagi bahosi
5,59
Aktivlardan daromad
Kapitaldan daromad
9,40%
Naqd pulning sof oʻzgarishi
(INR)mar, 2025Y/Y qiyosi
Sof foyda
21,50 mlrd-19,01%
Operatsiyalardan naqd pul
Sarmoyadan naqd pul
Moliyadan naqd pul
Naqd pulning sof oʻzgarishi
Boʻsh pul
Haqida
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. Around 70% of Sun Pharma’s revenue is generated from international markets. The US and India are the largest markets, accounting for over 60% of the company's turnover. Manufacturing is across 43 locations in India, the US, Asia, Africa, Australia and Europe. The products cater to therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin. Wikipedia
Tashkil etilgan
1983
Xodimlar soni
43 000
Yana
Bu sizni qiziqtirishi mumkin
Bu roʻyxat oxirgi qidiruvlar, kuzatilgan aksiyalar va boshqa faoliyatdan tuzilgan. Batafsil

Barcha axborotlar faqat maʼlumot sifatida “shundayligicha” taqdim etilgan, ulardan moliyaviy maslahat sifatida foydalanmang, ular savdo maqsadlari yoki investitsiya, soliq, yuridik, buxgalteriya yoki boshqa turdagi maslahat emas. Google investitsiya borasida maslahatchi emas, bu roʻyxatdagi kompaniyalar yoki ularning aksiyalari borasida hech qanday nuqtai nazar, tavsiya yoki fikr bildirmaydi. Har qanday savdoni boshlashdan oldin broker yoki moliyaviy vakil bilan maslahatlashib, narxlarni tekshiring. Batafsil
Aloqador qidiruvlar
Qidiruv
Qidiruv maydonini tozalash
Qidiruvni yopish
Google ilovalari
Asosiy menyu